-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA WITHDRAWS GSK’S APPROVAL OF WELLCOVORIN AS AUTISM TREATMENT - BLOOMBERG NEWS

Reuters·04/09/2026 19:50:35

Please log in to view news